IP Library › Granted Patent US 12,207,950
Granted Patent B2
US 12,207,950 · App. 16/985,745 · Granted Jan 28, 2025

Predictive monitoring of the glucose-insulin endocrine metabolic regulatory system

Inventors: Steven Catani (Athens, GA); Yinglong Guo (Roseville, MN); Benjamin W. Ehlert (Wayzata, MN); Cody James Lensing (Maple Grove, MN); Stephen Rushton Garth (Maplewood, MN)
Assignee: UnitedHealth Group Incorporated
A61B5/7275A61B5/14532A61B5/746G06N3/047G06N3/048G06N20/00G16H50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,207,950
App. No.
16/985,745
Granted
Jan 28, 2025
Kind
B2
Abstract

There is a need for more effective and efficient predictive data analysis, such as more effective and efficient data analysis solutions for performing predictive monitoring of the glucose-insulin endocrine metabolic regulatory system. Certain embodiments utilize systems, methods, and computer program products that perform predictive data analysis by utilizing at least one of glucose surge excursion detections, steady-state glucose-insulin machine learning models, and parameter space refinement machine learning models.

Claims (46)

1. A computer-implemented method comprising:

receiving, by one or more processors and from a continuous glucose monitoring (CGM) device, CGM data for an end-user;

determining, by the one or more processors, an excursion start time of the CGM data based at least in part on a plurality of excursion initiation probabilities for a plurality of temporal units associated with the CGM data;

determining, by the one or more processors, an excursion end time based at least in part on a plurality of excursion termination probabilities for a subset of the plurality of temporal units that occur after a predefined time interval following the excursion start time, wherein each excursion termination probability of the plurality of excursion termination probabilities is adjusted by an adjustment factor configured to:

(a) reward a latency of a corresponding temporal unit in an ordering of the subset of the plurality of temporal units, and

(b) penalize a precedence of the corresponding temporal unit in the ordering of the subset of the plurality of temporal units;

identifying, by the one or more processors, a time interval within the CGM data that corresponds to a glucose surge excursion based at least in part on the excursion start time and the excursion end time, wherein the time interval excludes the excursion start time and the excursion end time;

determining, by the one or more processors and based at least in part on a machine learning model that is trained using ground-truth data corresponding to the glucose surge excursion, one or more glucose-insulin predictions based at least in part on the glucose surge excursion; and

based at least in part on the one or more glucose-insulin predictions, performing an automated exogenous insulin injection into the end-user with an automated insulin delivery computing entity.

2. The computer-implemented method of claim 1 , wherein:

one or more of the plurality of excursion initiation probabilities are determined based at least in part on one or more of (i) a first comparison between a neighboring CGM moving average and a neighboring CGM moving average threshold, (ii) a first comparison between a CGM first derivative approximation and a CGM first derivative approximation threshold, or (iii) a first comparison between a CGM z-score and a CGM z-score threshold;

one or more of the plurality of excursion termination probabilities are determined based at least in part on one or more of (i) a second comparison between the neighboring CGM moving average and the neighboring CGM moving average threshold, (ii) a second comparison between the CGM first derivative approximation and the CGM first derivative approximation threshold, or (iii) a second comparison between the CGM z-score and the CGM z-score threshold; and

the neighboring CGM moving average threshold is determined based at least in part on a CGM measurement for a temporal unit of the plurality of temporal units and one or more CGM measurements for one or more temporal units of the plurality of temporal units preceding the temporal unit.

3. The computer-implemented method of claim 1 , wherein one or more of the plurality of excursion initiation probabilities are determined based at least in part on one or more user-supplied meal session initiation indicators.

4. The computer-implemented method of claim 1 , wherein one or more of the plurality of excursion termination probabilities are determined based at least in part on one or more user-supplied meal session termination indicators.

5. The computer-implemented method of claim 1 , wherein:

the plurality of excursion initiation probabilities is determined by providing CGM measurements to the machine learning model,

the machine learning model is configured to process the CGM measurements to generate the plurality of excursion initiation probabilities, and

the machine learning model is trained using the ground-truth data, wherein the ground-truth data is determined based at least in part on one or more user-supplied meal session initiation indicators.

6. The computer-implemented method of claim 1 , wherein:

the plurality of excursion termination probabilities is determined by providing CGM measurements associated with the subset of the plurality of temporal units to the machine learning model,

the machine learning model is configured to process the CGM measurements to generate the plurality of excursion termination probabilities, and

the machine learning model is trained using the ground-truth data, wherein the ground-truth data is determined based at least in part on one or more user-supplied meal session termination indicators.

7. The computer-implemented method of claim 1 , wherein the one or more glucose-insulin predictions comprise an insulin sensitivity prediction.

8. The computer-implemented method of claim 2 , wherein the neighboring CGM moving average threshold is 2.5 milligrams per deciliter per minute, the CGM first derivative approximation threshold is 2.5 milligrams per deciliter per minute, the CGM z-score threshold is 1.0, or any combination thereof.

9. The computer-implemented method of claim 1 , wherein the machine learning model comprises a steady-state glucose-insulin prediction machine learning model, a glucose-biased glucose-insulin predication machine learning model, a hybrid glucose-insulin predication machine learning model, an excursion termination detection machine learning model, a parameter space refinement machine learning model, or any combination thereof.

10. The computer-implemented method of claim 1 , wherein the machine learning model is configured using one or more quasi-global parameter optimization operations.

11. The computer-implemented method of claim 1 , wherein determining the excursion end time comprises:

determining one or more potential excursion end times based at least in part on the plurality of excursion initiation probabilities;

determining an excursion probability for a potential excursion end time of the one or more potential excursion end times, wherein the excursion probability is based at least in part on a temporal deviation between the excursion start time and the potential excursion end time; and

determining the excursion end time based at least in part on the excursion probability.

12. A system comprising one or more memories, one or more processors communicatively coupled to the one or more memories, and an automated insulin delivery computing entity, the one or more processors configured to:

receive, from a continuous glucose monitoring (CGM) device, CGM data for an end-user;

determine an excursion start time of the CGM data based at least in part on a plurality of excursion initiation probabilities for a plurality of temporal units associated with the CGM data;

determine an excursion end time based at least in part on a plurality of excursion termination probabilities for a subset of the plurality of temporal units that occur after a predefined time interval following the excursion start time, wherein each excursion termination probability of the plurality of excursion termination probabilities is adjusted by an adjustment factor configured to:

(a) reward a latency of a corresponding temporal unit in an ordering of the subset of the plurality of temporal units, and

(b) penalize a precedence of the corresponding temporal unit in the ordering of the subset of the plurality of temporal units;

identify a time interval within the CGM data that corresponds to a glucose surge excursion based at least in part on the excursion start time and the excursion end time, wherein the time interval excludes the excursion start time and the excursion end time;

determine, based at least in part on a machine learning model that is trained using ground-truth data corresponding to the glucose surge excursion, one or more glucose-insulin predictions based at least in part on the glucose surge excursion; and

based at least in part on the one or more glucose-insulin predictions, perform an automated exogenous insulin injection into the end-user with the automated insulin delivery computing entity.

13. The system of claim 12 , wherein one or more of the plurality of excursion initiation probabilities are determined based at least in part on one or more user-supplied meal session initiation indicators.

14. The system of claim 12 , wherein one or more of the plurality of excursion termination probabilities are determined based at least in part on one or more user-supplied meal session termination indicators.

15. The system of claim 12 , wherein:

the plurality of excursion initiation probabilities is determined by providing CGM measurements to the machine learning model,

the machine learning model is configured to process the CGM measurements to generate the plurality of excursion initiation probabilities, and

the machine learning model is trained using the ground-truth data, wherein the ground-truth data is determined based at least in part on one or more user-supplied meal session initiation indicators.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 7, 2020
From: CATANI, STEVEN; GUO, YINGLONG; EHLERT, BENJAMIN W.; LENSING, CODY JAMES; GARTH, STEPHEN RUSHTON
To: UNITEDHEALTH GROUP INCORPORATED
Reel/Frame 053427/0426 →
Continuity (1)
Related Publication 20220039757A1 · Feb 10, 2022
References Cited (44)
US 20110098548A1 · Budiman et al. · 2011 [cited by applicant]
US 20130211220A1 · Cobelli et al. · 2013 [cited by applicant]
US 20190252079A1 · Constantin et al. · 2019 [cited by applicant]
US 20200245913A1 · Dalal et al. · 2020 [cited by applicant]
US 20220346676A1 · Pecchia et al. · 2022 [cited by applicant]
US 20230080876A1 · Miyamoto · 2023 [cited by applicant]
EP 3395252A1 · 2018 [cited by applicant]
GB 2586788A · 2021 [cited by applicant]
Kölle, K., Biester, T., Christiansen, S., Fougner, A. L., & Stavdahl, Ø. (2019). Pattern recognition reveals characteristic postprandial glucose changes: Non-individualized meal detection in diabetes mellitus type 1. IE… [cited by examiner]
Cappon, G.; Facchinetti, A.; Sparacino, G.; Georgiou, P.; Herrero, P. Classification of Postprandial Glycemic Status with Application to Insulin Dosing in Type 1 Diabetes—An In Silico Proof-of-Concept. Sensors 2019, 19,… [cited by examiner]
Ajmera, I. et al. “The Impact Of Mathematical Modeling On The Understanding of Diabetes and Related Complications,” CPT: Pharmacometrics & Systems Pharmacology, vol. 2, No. 7, Jul. 10, 2013, pp. 1-14. DOI: 10.1038/psp.2… [cited by applicant]
Bergman, R.N. et al. “The Evolution of B-Cell Dysfunction and Insulin Resistance In Type 2 Diabetes,” European Journal of Clinical Investigation, vol. 32, Suppl. 3, (2002), pp. 35-45. [cited by applicant]
Cappon, Giacomo et al. “A Neural-Network-Based Approach to Personalize Insulin Bolus Calculation Using Continuous Glucose Monitoring,” Journal of Diabetes Science and Technology, (2018), vol. 12, Issue 2, pp. 265-272. D… [cited by applicant]
De Gaetano, Andrea et al. “Routine OGTT: A Robust Model Including Incretin Effect For Precise Identification of Insulin Sensitivity and Secretion In A Single Individual,” PLoS One, vol. 8, No. 8. e70875. DOI: 10.1371/jo… [cited by applicant]
Ferrannini, Ele et al. “How To Measure Insulin Sensitivity,” Journal of Hypertension, vol. 16, No. 7, (1998), pp. 895-906. [cited by applicant]
Hethcote, Herbert W. “The Mathematics Of Infectious Diseases,” SIAM review, vol. 42, No. 4, Dec. 2000, pp. 599-653. [Retrieved from the Internet Aug. 20, 2020] URL: http://www.maths.usyd.edu.au/u/marym/populations/hethc… [cited by applicant]
Lanzas, Cristina et al. “Complex System Modelling For Veterinary Epidemiology,” Preventive Veterinary Medicine, vol. 118, Issues 2-3, Feb. 1, 2015, pp. 207-214. DOI: 10.1016/j.prevetmed.2014.09.012. [cited by applicant]
Li, Jiaxu et al. “Analysis Of IVGTT Glucose-Insulin Interaction Models With Time Delay,” Discrete and Continuous Dynamical Systems—Series B, vol. 1, No. 1, Feb. 2001, pp. 103-124. [cited by applicant]
Li, Jiaxu et al. “Modeling The Glucose-Insulin Regulatory System and Ultradian Insulin Secretory Oscillations With Two Explicit Time Delays,” Journal of Theoretical Biology, vol. 242, (2006), pp. 722-735. [cited by applicant]
Li, Jiaxu et al. “The Range Of Time Delay and The Global Stability Of The Equilibrium For An IVGTT Model,” Mathematical Biosciences, vol. 235, (2012), pp. 128-137. [cited by applicant]
Li, Steven Cheng-Xian et al. “A Scalable End-To-End Gaussian Process Adapter For Irregularly Sampled Time Series Classification,” In Advances In Neural Information Processing Systems (NIPS), (2016), pp. 1804-1812. [cited by applicant]
McCallum, Hamish et al. “How Should Pathogen Transmission Be Modelled?,” Trends In Ecology & Evolution, vol. 16, No. 6, Jun. 2001, pp. 295-300. [cited by applicant]
Pacini, Giovanni et al. “MINMOD: A Computer Program To Calculate Insulin Sensitivity and Pancreatic Responsivity From The Frequently Sampled Intravenous Glucose Tolerance Test,” Computer Methods and Programs In Biomedic… [cited by applicant]
Steil, Garry M. et al. “Determination of Plasma Glucose During Rapid Glucose Excursions With A Subcutaneous Glucose Sensor,” Diabetes Technology & Therapeutics, vol. 5, No. 1, Jan. 2003, pp. 27-31. [cited by applicant]
Sun, Qingnan et al. “Reinforcement Learning-Based Adaptive Insulin Advisor For Individuals With Type 1 Diabetes Patients Under Multiple Daily Injections Therapy,” In 2019 41st Annual International Conference of the IEEE… [cited by applicant]
González-Rodríguez, Maria et al. “Postprandial Glycemic Response In A Non-Diabetic Adult Population: The Effect Of Nutrients Is Different Between Men and Women,” Nutrition & Metabolism, vol. 16, No. 46, Jul. 17, 2019, p… [cited by applicant]
NonFinal Office Action for U.S. Appl. No. 16/985,755, dated May 26, 2023, (19 pages), United States Patent and Trademark Office, US. [cited by applicant]
Brenner, Michael et al. “Estimation of Insulin Secretion, Glucose Uptake By Tissues, and Liver Handling Of Glucose Using A Mathematical Model Of Glucose-Insulin Homeostasis In Lean and Obese Mice,” Heliyon, vol. 3, Issu… [cited by applicant]
Cobelli, Claudio et al. “Diabetes: Models, Signals, and Control,” IEEE Reviews In Biomedical Engineering, vol. 2, pp. 54-96, Dec. 22, 2009 (ePub: Jan. 1, 2009), DOI: 10.1109/RBME.2009.2036073. [cited by applicant]
Huard, Benoit et al. “Investigation of Stability In A Two-Delay Model Of The Ultradian Oscillations In Glucose-Insulin Regulation,” Communications In Nonlinear Science and Numerical Simulation, vol. 26, Issues 1-3, Sep.… [cited by applicant]
NonFinal Office Action for U.S. Appl. No. 16/985,765, dated May 2, 2023, (16 pages), United States Patent and Trademark Office, US. [cited by applicant]
Percival, Matthew W. et al. “Modeling The Effects Of Subcutaneous Insulin Administration and Carbohydrate Consumption On Blood Glucose,” Journal of Diabetes Science and Technology, vol. 4, Issue 5, Sep. 2010, pp. 1214-1… [cited by applicant]
Singal, Pooja et al. “Simple Modeling Allows Prediction Of Steady-State Glucose Disposal Rate From Early Data In Hyperinsulinemic Glucose Clamps,” American Journal of Physiology-Endocrinology and Metabolism, vol. 298, N… [cited by applicant]
Woldaregay, Ashenafi Zebene et al. “Data-Driven Modeling and Prediction of Blood Glucose Dynamics: Machine Learning Applications In Type 1 Diabetes,” Artificial Intelligence In Medicine, vol. 98, Jul. 19, 2019, pp. 109-… [cited by applicant]
Final Office Action for U.S. Appl. No. 16/985,759, dated Nov. 16, 2023, (16 pages), United States Patent and Trademark Office, US. [cited by applicant]
Hall H, Perelman D, Breschi A, et al. Glucotypes reveal new patterns of glucose dysregulation. PLoS Biol. 2018;16(7):e2005143. Published Jul. 24, 2018. doi:10.1371/journal.pbio.2005143 (Year: 2018). [cited by applicant]
Michele Schiavon, Chiara Dalia Man, Yogish C. Kudva, Ananda Basu, Claudio Cobelli; Quantitative Estimation of Insulin Sensitivity in Type 1 Diabetic SubjectsWearing a Sensor-Augmented Insulin Pump. Diabetes Care May 1, … [cited by applicant]
Non-Final Rejection Mailed on Mar. 27, 2024 for U.S. Appl. No. 16/985,755, 23 page(s). [cited by applicant]
Advisory Action for U.S. Appl. No. 16/985,765, dated Nov. 3, 2023, (3 pages), United States Patent and Trademark Office, US. [cited by applicant]
Farmer, Jr. Terry G. et al. “Effectiveness Of Intravenous Infusion Algorithms For Glucose Control In Diabetic Patients Using Different Simulation Models,” Industrial & Engineering Chemistry Research, vol. 48, No. 9, pp.… [cited by applicant]
Final Office Action for U.S. Appl. No. 16/985,765, dated Aug. 18, 2023, (21 pages), United States Patent and Trademark Office, US. [cited by applicant]
Hall, Heather et al. “ Glucotypes Reveal New Patterns Of Glucose Dysregulation,” PLoS Biology, vol. 16, No. 7: e2005143, pp. 1-23, Jul. 24, 2018, (Year: 2018), DOI: 10.1371/journaal.pbio.2005143. [cited by applicant]
NonFinal Office Action for U.S. Appl. No. 16/985,759, dated Aug. 10, 2023, (12 pages), United States Patent and Trademark Office, US. [cited by applicant]
Notice of Allowance and Fees Due (PTOL-85) Mailed on Sep. 12, 2024 for U.S. Appl. No. 16/985,765, 2 page (s). [cited by applicant]
Cited By (1)
US 12,293,841